Pharma BD Deal Intelligence
CB Biotechnology, LLC (Future Pak) / Theratechnologies Inc.
2025 · Take-Private · Complete
Theratechnologies entered a binding arrangement agreement on July 2, 2025 under which CB Biotechnology, LLC, an affiliate of Future Pak, LLC, will acquire all issued and outstanding common shares for US$3.01 per share in cash plus one contingent value right per share. Aggregate transaction value not stated in the announcement.
This deal is too recent to grade. Critic Score and Outcome Score are assigned after the announcement-week coverage settles and, for Outcome, after the 5-year post-close assessment window opens — expected 2030 at the earliest for this deal, once/if it closes.
Key facts
- Announced Jul 02, 2025
- Deal type Take-Private
Related deals
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
More: 2025 deals